Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment

[1]  V. Perry,et al.  Review: Activation patterns of microglia and their identification in the human brain , 2013, Neuropathology and applied neurobiology.

[2]  Christine Van Broeckhoven,et al.  Genetic insights in Alzheimer's disease , 2013, The Lancet Neurology.

[3]  Britta Engelhardt,et al.  Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo , 2013, Fluids and Barriers of the CNS.

[4]  Jean-Philippe Michaud,et al.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology , 2013, Proceedings of the National Academy of Sciences.

[5]  L. Steinman.  Inflammatory Cytokines at the Summits of Pathological Signal Cascades in Brain Diseases , 2013, Science Signaling.

[6]  M. Schwartz,et al.  Harnessing monocyte‐derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’ , 2013, The Journal of pathology.

[7]  D. Begley,et al.  Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  E. Maggioli,et al.  Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications , 2012, Proceedings of the National Academy of Sciences.

[9]  Yen-Ching Chen,et al.  Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease , 2012, PloS one.

[10]  D. Cox,et al.  B cell exchange across the blood-brain barrier in multiple sclerosis. , 2012, The Journal of clinical investigation.

[11]  R. Nau,et al.  The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells , 2012, Journal of Neuroimmunology.

[12]  L. Prensa,et al.  Correction: Stereological Analysis of Neuron, Glial and Endothelial Cell Numbers in the Human Amygdaloid Complex , 2012, PLoS ONE.

[13]  M. Pomper,et al.  Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood–brain barrier through paracellular transmigration and ERK activation , 2012, Journal of Neuroinflammation.

[14]  W. Banks,et al.  Insulin in the brain: there and back again. , 2012, Pharmacology & therapeutics.

[15]  S. Rivest,et al.  Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APPSwe/PS1 mice , 2012, Front. Cell. Neurosci..

[16]  V. Pascual,et al.  From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines , 2012, Nature Immunology.

[17]  J. Tanus-Santos,et al.  Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients , 2012, Journal of Neuroimmunology.

[18]  D. Hermann,et al.  The Abluminal Endothelial Membrane in Neurovascular Remodeling in Health and Disease , 2012, Science Signaling.

[19]  R. Ransohoff,et al.  Inflammatory cell trafficking across the blood–brain barrier: chemokine regulation and in vitro models , 2012, Immunological reviews.

[20]  T. Kielian,et al.  Toll-like receptor (TLR) and inflammasome actions in the central nervous system. , 2012, Trends in immunology.

[21]  S. Rivest,et al.  The neuroendocrine control of the innate immune system in health and brain diseases , 2012, Immunological reviews.

[22]  Lucía Prensa,et al.  Stereological Analysis of Neuron, Glial and Endothelial Cell Numbers in the Human Amygdaloid Complex , 2012, PloS one.

[23]  S. Rivest,et al.  Effects of Myeloablation, Peripheral Chimerism, and Whole-Body Irradiation on the Entry of Bone Marrow-Derived Cells into the Brain , 2012, Cell transplantation.

[24]  H. Müller,et al.  Chemokines in CNS injury and repair , 2012, Cell and Tissue Research.

[25]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[26]  Jin-Tai Yu,et al.  Common variants in toll-like receptor 4 confer susceptibility to Alzheimer's disease in a Han Chinese population. , 2012, Current Alzheimer research.

[27]  L. Tan,et al.  Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease , 2012, Journal of the Neurological Sciences.

[28]  Nathan T. Ross,et al.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.

[29]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[30]  P. Ricciardi-Castagnoli,et al.  The rhapsody of NLRPs: master players of inflammation … and a lot more , 2012, Immunologic Research.

[31]  C. Moraes,et al.  Lessons from genome‐wide association studies findings in Alzheimer's disease , 2012, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[32]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[33]  D. Hume,et al.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.

[34]  Wei Zheng,et al.  Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. , 2012, Pharmacology & therapeutics.

[35]  A. Saghatelyan,et al.  Astrocytes Control the Development of the Migration-Promoting Vasculature Scaffold in the Postnatal Brain via VEGF Signaling , 2012, The Journal of Neuroscience.

[36]  Oskar Hansson,et al.  CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease , 2012, PloS one.

[37]  T. Deerinck,et al.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation , 2012, Nature Communications.

[38]  F. Charron,et al.  The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.

[39]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[40]  M. Bhide,et al.  An insight into the ligand-receptor interactions involved in the translocation of pathogens across blood-brain barrier. , 2011, FEMS immunology and medical microbiology.

[41]  C. Larochelle,et al.  How do immune cells overcome the blood–brain barrier in multiple sclerosis? , 2011, FEBS letters.

[42]  M. Schwartz,et al.  Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis , 2011, PloS one.

[43]  T. Kielian,et al.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. , 2011, Clinical science.

[44]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[45]  W. Banks,et al.  Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide , 2011, Journal of Neuroinflammation.

[46]  W. Bowers,et al.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain. , 2011, The American journal of pathology.

[47]  S. Rivest,et al.  Immune Mechanisms Underlying the Beneficial Effects of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis , 2011, Neurotherapeutics.

[48]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[49]  Jamaal A Rehman,et al.  TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[50]  H. Rosenzweig,et al.  NLRs in immune privileged sites. , 2011, Current opinion in pharmacology.

[51]  Tomohiro Watanabe,et al.  NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.

[52]  W. M. van der Flier,et al.  Blood-brain barrier p-glycoprotein function in Alzheimer's disease , 2011, Alzheimer's & Dementia.

[53]  S. Rivest,et al.  Targeting the hematopoietic system for the treatment of Alzheimer’s disease , 2011, Brain, Behavior, and Immunity.

[54]  D. Hermann,et al.  ATP-Binding Cassette Transporters and Their Roles in Protecting the Brain , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[55]  S. Rivest,et al.  CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[56]  Michael Martin,et al.  TLR-signaling Networks , 2011, Journal of dental research.

[57]  L. Tan,et al.  Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer's disease in a Han Chinese population , 2011, Brain Research.

[58]  V. Yong,et al.  The many faces of EMMPRIN - roles in neuroinflammation. , 2011, Biochimica et biophysica acta.

[59]  M. Gassmann,et al.  Astrocytes and Pericytes Differentially Modulate Blood—Brain Barrier Characteristics during Development and Hypoxic Insult , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  H. D. de Vries,et al.  Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. , 2011, Brain : a journal of neurology.

[61]  Jean-Philippe Michaud,et al.  MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease , 2011, Molecular Neurodegeneration.

[62]  W. Tourtellotte,et al.  EMMPRIN: A Novel Regulator of Leukocyte Transmigration into the CNS in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2011, The Journal of Neuroscience.

[63]  S. Akira,et al.  Pathogen Recognition by the Innate Immune System , 2011, International reviews of immunology.

[64]  C. Boularan,et al.  Meningococcus Hijacks a β2-Adrenoceptor/β-Arrestin Pathway to Cross Brain Microvasculature Endothelium , 2010, Cell.

[65]  Ulrich Dirnagl,et al.  Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain , 2010, Proceedings of the National Academy of Sciences.

[66]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[67]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[68]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[69]  I. Wilhelm,et al.  Expression and regulation of toll-like receptors in cerebral endothelial cells , 2010, Neurochemistry International.

[70]  D. Hermann,et al.  Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain , 2010, Science Signaling.

[71]  H. Neumann,et al.  Protective effects of microglia in multiple sclerosis , 2010, Experimental Neurology.

[72]  H. Anders,et al.  Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. , 2010, International immunology.

[73]  G. Conductier,et al.  The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases , 2010, Journal of Neuroimmunology.

[74]  David J. Miller,et al.  Human Neuronal Cells Possess Functional Cytoplasmic and TLR-Mediated Innate Immune Pathways Influenced by Phosphatidylinositol-3 Kinase Signaling , 2010, The Journal of Immunology.

[75]  J. Koistinaho,et al.  The role and therapeutic potential of monocytic cells in Alzheimer's disease , 2010, Glia.

[76]  V. Grdzelishvili,et al.  Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. , 2010, Virology.

[77]  C. Hunter,et al.  Trafficking of immune cells in the central nervous system. , 2010, The Journal of clinical investigation.

[78]  E. Aronica,et al.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures , 2010, Nature Medicine.

[79]  L. Doering,et al.  Astrocytes Prevent Abnormal Neuronal Development in the Fragile X Mouse , 2010, The Journal of Neuroscience.

[80]  M. Yoneyama,et al.  Recognition of viral nucleic acids in innate immunity , 2010, Reviews in medical virology.

[81]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[82]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[83]  A. Fraire,et al.  Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology , 2009, Journal of Virology.

[84]  G. Landreth,et al.  CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation , 2009, The Journal of Neuroscience.

[85]  Turgay Dalkara,et al.  Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery , 2009, Nature Medicine.

[86]  U. Heinemann,et al.  Blood–brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy , 2009, Epilepsy Research.

[87]  B. Imbimbo.  An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease , 2009, Expert opinion on investigational drugs.

[88]  E. Ringelstein,et al.  Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice , 2009, Neuroscience.

[89]  P. Couraud,et al.  Meningococcal Type IV Pili Recruit the Polarity Complex to Cross the Brain Endothelium , 2009, Science.

[90]  Dirk E. Smith,et al.  A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. , 2009, Immunity.

[91]  S. Rivest.  Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[92]  M. Marta,et al.  Regulation of autoimmune encephalomyelitis by toll-like receptors. , 2009, Autoimmunity reviews.

[93]  L. Lue,et al.  ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.

[94]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[95]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[96]  R. Koehler,et al.  Astrocytes and the regulation of cerebral blood flow , 2009, Trends in Neurosciences.

[97]  A. Testori,et al.  Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study , 2009, The Lancet Neurology.

[98]  R. Hohlfeld,et al.  Multiple sclerosis therapeutics , 2009, Neurology.

[99]  H. Lassmann,et al.  Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis , 2008, Journal of leukocyte biology.

[100]  F. Licastro,et al.  Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. , 2008, Current pharmaceutical design.

[101]  S. Rivest,et al.  Bone-marrow-derived microglia: myth or reality? , 2008, Current opinion in pharmacology.

[102]  M. Diamond,et al.  Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection , 2008, Journal of Virology.

[103]  Jun Tan,et al.  Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.

[104]  R. Deane,et al.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. , 2008, Current pharmaceutical design.

[105]  K. L. Richard,et al.  Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[106]  J. Relton,et al.  Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[107]  M. Yano,et al.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells , 2008, Journal of NeuroVirology.

[108]  A. Prat,et al.  The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. , 2008, Brain : a journal of neurology.

[109]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[110]  R. Pierce,et al.  Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. , 2007, Blood.

[111]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[112]  Maria L. D. Udan,et al.  Toll‐like receptors 2 and 4 mediate Aβ(1–42) activation of the innate immune response in a human monocytic cell line , 2007, Journal of neurochemistry.

[113]  R. Tibshirani,et al.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.

[114]  J. Bergelson,et al.  In brief , 2007, Nature Reviews Microbiology.

[115]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[116]  D. Edelman,et al.  Lipopolysaccharide activation of pericyte's Toll-like receptor-4 regulates co-culture permeability. , 2007, American journal of surgery.

[117]  E. Dejana,et al.  Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation1 , 2007, The Journal of Immunology.

[118]  F. Maxfield,et al.  Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. , 2007, Molecular biology of the cell.

[119]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[120]  E. Aronica,et al.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. , 2007, Brain : a journal of neurology.

[121]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[122]  Michael I Dorrell,et al.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.

[123]  D. Feinstein,et al.  The heat‐shock protein 90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis , 2006, Journal of neurochemistry.

[124]  C. Brosnan,et al.  IL-1β Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program1 , 2006, The Journal of Immunology.

[125]  B. Melchior,et al.  CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.

[126]  Ling Li,et al.  Role of toll-like receptor signalling in Abeta uptake and clearance. , 2006, Brain : a journal of neurology.

[127]  G. D. del Zoppo,et al.  Integrin-matrix interactions in the cerebral microvasculature. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[128]  L. O’Neill,et al.  TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. , 2006, Trends in immunology.

[129]  G. Opdenakker,et al.  Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.

[130]  J. Julien,et al.  Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.

[131]  C. Gazzaruso,et al.  Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease , 2006, Neuroscience Letters.

[132]  A. Butt,et al.  Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions , 2006, Journal of cellular and molecular medicine.

[133]  A. Fagan,et al.  P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.

[134]  M. Toborek,et al.  Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[135]  H. Weiner,et al.  Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells , 2005, Journal of Neuroimmunology.

[136]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[137]  P. Grammas,et al.  HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia , 2005, Journal of neuropathology and experimental neurology.

[138]  C. Brosnan,et al.  IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery , 2005, Glia.

[139]  A. Vezzani.  Inflammation and Epilepsy , 2005, Epilepsy currents.

[140]  S. Miller,et al.  Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1 , 2004, The Journal of Immunology.

[141]  Peter J. Lenting,et al.  LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms , 2004, Neuron.

[142]  D. Srinivasan,et al.  Cell Type-Specific Interleukin-1β Signaling in the CNS , 2004, The Journal of Neuroscience.

[143]  S. Murphy,et al.  Neisseria meningitidis‐induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase , 2004, Journal of neurochemistry.

[144]  S. Rivest,et al.  Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[145]  K. Nicolay,et al.  Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.

[146]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[147]  Ole P. Ottersen,et al.  The molecular basis of water transport in the brain , 2003, Nature Reviews Neuroscience.

[148]  C. Polman,et al.  New and emerging treatment options for multiple sclerosis , 2003, The Lancet Neurology.

[149]  Ann Marie Schmidt,et al.  RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.

[150]  Helga E de Vries,et al.  The Blood‐Brain Barrier and Its Role in Immune Privilege in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.

[151]  W. Pardridge.  Blood-brain barrier drug targeting: the future of brain drug development. , 2003, Molecular interventions.

[152]  S. Fu,et al.  FTY720 stimulates multidrug transporter– and cysteinyl leukotriene–dependent T cell chemotaxis to lymph nodes , 2003 .

[153]  P. Sawchenko,et al.  Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults , 2002, The Journal of Neuroscience.

[154]  T. Wisniewski,et al.  Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. , 2002, Vascular pharmacology.

[155]  J. Antel,et al.  Migration of multiple sclerosis lymphocytes through brain endothelium. , 2002, Archives of neurology.

[156]  U. Dirnagl,et al.  Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages , 2001, The European journal of neuroscience.

[157]  K. Frei,et al.  Molecular and cellular permeability control at the blood–brain barrier , 2001, Brain Research Reviews.

[158]  D. Chaplin,et al.  Interleukin-1β Promotes Repair of the CNS , 2001, The Journal of Neuroscience.

[159]  L. Kappos,et al.  The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. , 2001, Brain : a journal of neurology.

[160]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[161]  P. Luiten,et al.  Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.

[162]  G. van Meer,et al.  Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. , 2001, The Biochemical journal.

[163]  Holger Gerhardt,et al.  Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis , 2001, The Journal of cell biology.

[164]  D. Dobbelaere,et al.  Soluble interleukin-1 receptor--reverse signaling in innate immunoregulation. , 2001, Cytokine & growth factor reviews.

[165]  J. Greenwood,et al.  ICAM-1-Coupled Cytoskeletal Rearrangements and Transendothelial Lymphocyte Migration Involve Intracellular Calcium Signaling in Brain Endothelial Cell Lines1 , 2000, The Journal of Immunology.

[166]  V. Yong,et al.  Central Nervous System-Initiated Inflammation and Neurotrophism in Trauma: IL-1β Is Required for the Production of Ciliary Neurotrophic Factor1 , 2000, The Journal of Immunology.

[167]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[168]  W. Thomas,et al.  Cellular mechanisms of CNS pericytes , 2000, Brain Research Bulletin.

[169]  S. Rivest,et al.  An Essential Role of Interleukin-1β in Mediating NF-κB Activity and COX-2 Transcription in Cells of the Blood–Brain Barrier in Response to a Systemic and Localized Inflammation But Not During Endotoxemia , 1999, The Journal of Neuroscience.

[170]  K. Furuuchi,et al.  Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. , 1999, Biochemical and biophysical research communications.

[171]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[172]  J. Weiss,et al.  Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. , 1998, Journal of immunology.

[173]  L. Kappos,et al.  Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. , 1998, Brain : a journal of neurology.

[174]  H. Akiyama,et al.  Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. , 1997, Stroke.

[175]  A. Kastin,et al.  HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. , 1997, Life sciences.

[176]  J. Durkin,et al.  The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion , 1997, Journal of Neuroimmunology.

[177]  M. Moskowitz,et al.  Expression of a Dominant Negative Mutant of Interleukin-1β Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury , 1997, The Journal of experimental medicine.

[178]  M. Santucci,et al.  Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[179]  P. Dore‐Duffy,et al.  CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2. , 1996, Microvascular research.

[180]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[181]  H. D. de Vries,et al.  Interleukin‐1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[182]  P. Kochanek,et al.  Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain , 1996, Annals of neurology.

[183]  G. Kreutzberg,et al.  Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.

[184]  R. Fine,et al.  Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. , 1994, Biochemical pharmacology.

[185]  W. Banks,et al.  Blood to Brain and Brain to Blood Passage of Native Horseradish Peroxidase, Wheat Germ Agglutinin, and Albumin: Pharmacokinetic and Morphological Assessments , 1994, Journal of neurochemistry.

[186]  F E Bloom,et al.  Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Firth,et al.  Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. , 1993, Journal of cell science.

[188]  A. Reder,et al.  Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.

[189]  M. Graeber,et al.  New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury , 1990, Journal of Neuroimmunology.

[190]  E. Benveniste,et al.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. , 1990, Journal of immunology.

[191]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[192]  W. Hickey,et al.  Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.

[193]  L. Rakić,et al.  Transport of Leucine‐Enkephalin Across the Blood‐Brain Barrier in the Perfused Guinea Pig Brain , 1987, Journal of neurochemistry.

[194]  L. Curtiss,et al.  Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. , 1986, Journal of immunology.

[195]  N. Geschwind,et al.  Temporal lobe epilepsy , 1984, Neurology.

[196]  W. Baumgärtner,et al.  Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.

[197]  B. Kamińska,et al.  TGF beta signaling and its role in glioma pathogenesis. , 2013, Advances in experimental medicine and biology.

[198]  A. Vezzani,et al.  Inflammation and epilepsy. , 2012, Handbook of clinical neurology.

[199]  L. Minthon,et al.  CCL 2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer ’ s Disease , 2012 .

[200]  V. Grdzelishvili,et al.  Characterization of retinoic acid—inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus , 2011, Journal of NeuroVirology.

[201]  K. Beck,et al.  Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β , 2011, Cell and Tissue Research.

[202]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[203]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[204]  J. Ringman,et al.  Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. , 2005, Journal of Alzheimer's disease : JAD.

[205]  R. Deane,et al.  LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. , 2004, Neuron.

[206]  D. Chaplin,et al.  Interleukin-1beta promotes repair of the CNS. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[207]  M. Takeichi.  Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[208]  P. Dore‐Duffy,et al.  Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. , 1993, Advances in experimental medicine and biology.

[209]  R. Terkeltaub,et al.  Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. , 1991, The Journal of clinical investigation.